We are live on ! Find out more
AHCO icon

AdaptHealth

225 hedge funds and large institutions have $1.23B invested in AdaptHealth in 2025 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 84 increasing their positions, 79 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 21

3% more funds holding

Funds holding: 219225 (+6)

6% more repeat investments, than reductions

Existing positions increased: 84 | Existing positions reduced: 79

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0.1% less ownership

Funds ownership: 101.27%101.17% (-0.1%)

5% less capital invested

Capital invested by funds: $1.29B → $1.23B (-$63.2M)

42% less call options, than puts

Call options by funds: $30.8M | Put options by funds: $52.9M

Holders
225
Holders Change
+6
Holders Change %
+2.74%
% of All Funds
2.94%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
29
Increased
84
Reduced
79
Closed
21
Calls
$30.8M
Puts
$52.9M
Net Calls
-$22.1M
Net Calls Change
+$5.62M

AHCO Hedge Fund Activity: Q3 2025 in Review

225 of the 7,641 institutional investors tracked by Wall St. Rank reported a position in AdaptHealth (AHCO) for Q3 2025, worth a combined $1.23B — down 4.9% from $1.29B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new AHCO positions and 21 closed out — a net gain of 8 holders — while 84 added to existing stakes and 79 trimmed.

The largest buyer was Deerfield Management, adding an estimated $14.6M. The largest seller was Royce & Associates, exiting entirely with an estimated $10.2M sold.

  • 225 institutional investors held AdaptHealth (AHCO) as of Q3 2025, up from 219 in Q2 2025.
  • Funds reported $1.23B of AdaptHealth stock for Q3 2025, down 4.9% quarter-over-quarter.
  • 29 funds opened new AdaptHealth positions in Q3 2025 and 21 closed out, a net change of +8 holders.
  • The largest AdaptHealth buyer in Q3 2025 was Deerfield Management, an estimated $14.6M added.
  • The largest AdaptHealth seller in Q3 2025 was Royce & Associates, an estimated $10.2M sold.

Based on aggregated 13F filings for Q3 2025.